dwinnex.com

Calithera Biosciences, Inc. [NASDAQ: CALA] stock went down by -13.71% or -0.65 points down from its previous closing price of $4.74. The stock reached $4.09 during the last trading session. During the course of the last 5 trading session in the week, CALA share price went up during 2 out of 5 days, that way losing -23.12% in the period of the last 7 days.

CALA had two major price movements with the latest trading session as the price jumped to a high of $4.23, at one point touching $3.92. The latest high is set lower that the high price recorded in the period of the last 52 weeks, set at $4.23. The 52-week high currently stands at $6.90 distance from the present share price, noting recovery -21.35% after the recent low of $3.55.

Calithera Biosciences, Inc. [NASDAQ:CALA]: Analyst Rating and Earnings

Pro stock traders frequently make sure to pay attention what expert market analysts are saying about a potential stock buy. Regarding Calithera Biosciences, Inc. [CALA] right now, the most recent ratings from Wall St. analysts that we can see right now is regarding the quarter that’s slated to end in December. On average, stock market experts give CALA an Buy rating. Its stock price has been found in the range of 3.55 to 6.90. This is compared to its latest closing price of $4.74.

Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Calithera Biosciences, Inc. [CALA] is sitting at 1.00. This is compared to 1 month ago, when its average rating was 1.20.

Keep your eyes peeled for the next scheduled financial results to be made public for this company, which are scheduled to be released on Tue 6 Aug (In 48 Days).

Fundamental Analysis of Calithera Biosciences, Inc. [CALA]

Now let’s turn to look at profitability: with a current Operating Margin for Calithera Biosciences, Inc. [CALA] sitting at -257.40.

This company’s Return on Total Capital is -41.35, and its Return on Invested Capital has reached -45.20%. Its Return on Equity is -39.44, and its Return on Assets is -32.60. These metrics suggest that this Calithera Biosciences, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

What about valuation? This company’s Enterprise Value to EBITDA is -1.20. The Enterprise Value to Sales for this firm is now 4.00. Calithera Biosciences, Inc. [CALA] has a Price to Book Ratio of 1.23.

Shifting the focus to workforce efficiency, Calithera Biosciences, Inc. [CALA] earns $281,696 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 14.18 and its Total Asset Turnover is 0.13. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 9.42 and its Current Ratio is 9.42. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Calithera Biosciences, Inc. [CALA] has 40.75M shares outstanding, amounting to a total market cap of $166.67M. Its stock price has been found in the range of 3.55 to 6.90. At its current price, it has moved down by -40.72% from its 52-week high, and it has moved up 15.21% from its 52-week low.

This stock’s Relative Strength Index (RSI) is at 30.38. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is Calithera Biosciences, Inc. [CALA] a Reliable Buy?

Calithera Biosciences, Inc. [CALA] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.